Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States.
Mayo Clinic in Arizona , Scottsdale , Arizona 85259 , United States.
Biochemistry. 2019 Dec 10;58(49):4983-4996. doi: 10.1021/acs.biochem.9b00863. Epub 2019 Nov 20.
von Willebrand A domain-containing protein 8 (VWA8) is a poorly characterized, mitochondrial matrix-targeted protein with an AAA ATPase domain and ATPase activity that increases in livers of mice fed a high-fat diet. This study was undertaken to use CRISPR/Cas9 to delete VWA8 in cultured mouse hepatocytes and gain insight into its function. Unbiased omics techniques and bioinformatics were used to guide subsequent assays, including the assessment of oxidative stress and the determination of bioenergetic capacity. Metabolomics analysis showed VWA8 null cells had higher levels of oxidative stress and protein degradation; assays of hydrogen peroxide production revealed higher levels of production of reactive oxygen species (ROS). Proteomics and transcriptomics analyses showed VWA8 null cells had higher levels of expression of mitochondrial proteins (electron transport-chain Complex I, ATP synthase), peroxisomal proteins, and lipid transport proteins. The pattern of higher protein abundance in the VWA8 null cells could be explained by a higher level of hepatocyte nuclear factor 4 α (HNF4α) expression. Bioenergetic assays showed higher rates of carbohydrate oxidation and mitochondrial and nonmitochondrial lipid oxidation in intact and permeabilized cells. Inhibitor assays localized sites of ROS production to peroxisomes and NOX1/4. The rescue of VWA8 protein restored the wild-type phenotype, and treatment with antioxidants decreased the level of HNF4α expression. Thus, loss of VWA8 produces a mitochondrial defect that may be sensed by NOX4, leading to an increase in the level of ROS that results in a higher level of HNF4α. The compensatory HNF4α response results in a higher oxidative capacity and an even higher level of ROS production. We hypothesize that VWA8 is an AAA ATPase protein that plays a role in mitochondrial protein quality.
血管性血友病因子 A 结构域蛋白 8(VWA8)是一种功能尚未完全阐明的线粒体基质靶向蛋白,具有 AAA ATP 酶结构域和 ATP 酶活性,在高脂饮食喂养的小鼠肝脏中其活性增加。本研究旨在使用 CRISPR/Cas9 技术在培养的小鼠肝细胞中敲除 VWA8,以深入了解其功能。采用无偏的组学技术和生物信息学方法来指导后续的检测,包括氧化应激评估和生物能量学能力测定。代谢组学分析显示,VWA8 缺失细胞的氧化应激和蛋白质降解水平更高;过氧化氢生成检测显示,活性氧(ROS)的产生水平更高。蛋白质组学和转录组学分析显示,VWA8 缺失细胞中线粒体蛋白(电子传递链复合物 I、ATP 合酶)、过氧化物酶体蛋白和脂质转运蛋白的表达水平更高。VWA8 缺失细胞中更高水平的蛋白质丰度模式可以通过更高水平的肝细胞核因子 4α(HNF4α)表达来解释。生物能量学检测显示,完整和通透细胞中糖氧化、线粒体和非线粒体脂质氧化的速率更高。抑制剂检测将 ROS 产生的部位定位于过氧化物酶体和 NOX1/4。VWA8 蛋白的恢复挽救了野生型表型,抗氧化剂处理降低了 HNF4α 的表达水平。因此,VWA8 的缺失会导致线粒体缺陷,这可能被 NOX4 感知,导致 ROS 水平升高,从而导致 HNF4α 水平升高。代偿性的 HNF4α 反应导致更高的氧化能力和更高水平的 ROS 产生。我们假设 VWA8 是一种 AAA ATP 酶蛋白,在维持线粒体蛋白质质量方面发挥作用。